𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: results from two transplant centres

✍ Scribed by Stephen D. Smith; Craig H. Moskowitz; Robert Dean; Brad Pohlman; Ronald Sobecks; Edward Copelan; Steven Andresen; Brian Bolwell; Jocelyn C. Maragulia; Jill M. Vanak; John Sweetenham; Alison J. Moskowitz

Book ID
108677198
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
138 KB
Volume
153
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

LACE-conditioned autologous stem cell tr
LACE-conditioned autologous stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma: treatment outcome and risk factor analysis from a single centre
✍ JiΕ™Γ­ PavlΕ―; Holger W. Auner; Sarah Ellis; Richard M. Szydlo; Chrissy Giles; Alej πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 109 KB

High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is a recognized treatment option for patients with relapsed diffuse large B-cell lymphoma. We have analysed 51 patients who underwent ASCT after LACE (lomustine (CCNU), cytarabine (Ara-C), cyclophosphamide, etoposide) con

Therapeutic results in patients with rel
Therapeutic results in patients with relapsed diffuse large B cell Non-Hodgkin's lymphoma achieving complete response only after autologous stem cell transplantation
✍ Felicetto Ferrara; Assunta Viola; Carolina Copia; Ettore Mariano Schiavone; Mari πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 92 KB

## Abstract Forty patients with relapsed diffuse large B cell lymphoma (DLBCL) autografted in partial response (PR) (__n__ = 23) or in refractory relapse (RR) (__n__ = 17) achieved complete remission (CR) after autologous stem cell transplantation (ASCT). Salvage treatment consisted of ifosphamide,